{"disease":{"id":"ventricular-arrhythmia","name":"Ventricular Arrhythmia","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":14,"pipeline_drug_count":0,"trial_count":5},"drugs":{"marketed":[{"drug_id":"flecainide","indication_name":"Documented Ventricular Arrhythmias","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tambocor","generic_name":"FLECAINIDE","company_name":"","drug_phase":"marketed","molecular_target":"Potassium voltage-gated channel subfamily H member 2","drug_class":"Antiarrhythmic","quality_score":59,"revenue":null,"mechanism":""},{"drug_id":"mexiletine","indication_name":"Ventricular Arrhythmias","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mexitil","generic_name":"MEXILETINE","company_name":"Boehringer Ingelheim","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 2B","drug_class":"Antiarrhythmic","quality_score":66,"revenue":null,"mechanism":"Mexitil works by blocking abnormal electrical signals in the heart to restore a normal heartbeat."},{"drug_id":"mexiletine-hydrochloride","indication_name":"Ventricular Arrhythmias","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"MEXILETINE HYDROCHLORIDE","company_name":"","drug_phase":"marketed","molecular_target":"sodium channels","drug_class":"","quality_score":53,"revenue":null,"mechanism":"Mexiletine, an oral antiarrhythmic, reduces ventricular arrhythmias by inhibiting sodium currents and altering refractory periods."},{"drug_id":"flecainide-acetate","indication_name":"Documented Ventricular Arrhythmias","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"FLECAINIDE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":38,"revenue":null,"mechanism":null},{"drug_id":"ajmaline","indication_name":"Supraventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ajmalin","generic_name":"AJMALINE","company_name":"","drug_phase":"phase_3","molecular_target":"Potassium voltage-gated channel subfamily A member 5","drug_class":"ajmaline","quality_score":36,"revenue":null,"mechanism":"Ajmaline works by blocking potassium channels in the heart to help regulate heart rhythm."},{"drug_id":"ajmaline","indication_name":"Ventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Ajmalin","generic_name":"AJMALINE","company_name":"","drug_phase":"phase_3","molecular_target":"Potassium voltage-gated channel subfamily A member 5","drug_class":"ajmaline","quality_score":36,"revenue":null,"mechanism":"Ajmaline works by blocking potassium channels in the heart to help regulate heart rhythm."},{"drug_id":"bretylium","indication_name":"Ventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bretylium Tosylate","generic_name":"BRETYLIUM","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Beta-1 adrenergic receptor","drug_class":"bretylium","quality_score":36,"revenue":null,"mechanism":""},{"drug_id":"disopyramide","indication_name":"Ventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Norpace Cr","generic_name":"DISOPYRAMIDE","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Histamine H1 receptor","drug_class":"Antiarrhythmic","quality_score":50,"revenue":null,"mechanism":""},{"drug_id":"non-interventional-study","indication_name":"Ventricular Arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Non-Interventional Study","generic_name":"non-interventional-study","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Vitamin K epoxide reductase","drug_class":"Anticoagulant","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"moracizine","indication_name":"Ventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"moracizine","company_name":"","drug_phase":"unknown","molecular_target":"Sodium channel protein type 5 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"lignocaine","indication_name":"Ventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lignocaine","company_name":"University of Malaya","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":19,"revenue":null,"mechanism":null},{"drug_id":"mexiletine","indication_name":"Ventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mexitil","generic_name":"MEXILETINE","company_name":"Boehringer Ingelheim","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 2B","drug_class":"Antiarrhythmic","quality_score":66,"revenue":null,"mechanism":"Mexitil works by blocking abnormal electrical signals in the heart to restore a normal heartbeat."},{"drug_id":"lidocaine-hydrochloride","indication_name":"Ventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lignospan Forte","generic_name":"Lidocaine Hydrochloride","company_name":"Fresenius Kabi","drug_phase":"marketed","molecular_target":"neuronal membrane ionic channels","drug_class":"local anesthetic, amide type","quality_score":68,"revenue":null,"mechanism":"Lidocaine stabilizes neuronal membrane by inhibiting ionic fluxes required for impulse initiation and conduction."},{"drug_id":"ethacizine","indication_name":"Supraventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Etacizin","generic_name":"ethacizine","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"ethacizine","quality_score":null,"revenue":null,"mechanism":"Etacizin works by blocking potassium channels in the heart, which helps to regulate abnormal heart rhythms."},{"drug_id":"ethacizine","indication_name":"Ventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Etacizin","generic_name":"ethacizine","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"ethacizine","quality_score":null,"revenue":null,"mechanism":"Etacizin works by blocking potassium channels in the heart, which helps to regulate abnormal heart rhythms."},{"drug_id":"detajmium","indication_name":"Supraventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tachmalcor","generic_name":"detajmium","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"detajmium","quality_score":null,"revenue":null,"mechanism":"Tachmalcor works by stabilizing cardiac ion channels to regulate abnormal heart rhythms."},{"drug_id":"detajmium","indication_name":"Ventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tachmalcor","generic_name":"detajmium","company_name":"","drug_phase":"unknown","molecular_target":"","drug_class":"detajmium","quality_score":null,"revenue":null,"mechanism":"Tachmalcor works by stabilizing cardiac ion channels to regulate abnormal heart rhythms."},{"drug_id":"aprindine","indication_name":"Supraventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fiboran","generic_name":"APRINDINE","company_name":"","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"aprindine","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"aprindine","indication_name":"Ventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Fiboran","generic_name":"APRINDINE","company_name":"","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"aprindine","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"norpace","indication_name":"Documented ventricular arrhythmias","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Norpace Cr","generic_name":"Disopyramide Phosphate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"G protein-activated inward rectifier potassium channel 4","drug_class":"High Risk QT Prolonging Agents","quality_score":10,"revenue":null,"mechanism":"Norpace is a sodium channel blocker and a Class 1a anti-arrhythmic agent."},{"drug_id":"norpace","indication_name":"Life-threatening ventricular arrhythmias","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Norpace Cr","generic_name":"Disopyramide Phosphate","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"G protein-activated inward rectifier potassium channel 4","drug_class":"High Risk QT Prolonging Agents","quality_score":10,"revenue":null,"mechanism":"Norpace is a sodium channel blocker and a Class 1a anti-arrhythmic agent."},{"drug_id":"prajmalium","indication_name":"Ventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prajmaline","generic_name":"PRAJMALIUM","company_name":"","drug_phase":"phase_2","molecular_target":"","drug_class":"prajmalium","quality_score":null,"revenue":null,"mechanism":"Prajmaline works by blocking sodium channels in the heart, which helps to regulate abnormal heart rhythms."},{"drug_id":"adenosine-triphosphate","indication_name":"Supraventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Triphosphoric Acid Adenosine Ester","generic_name":"ADENOSINE TRIPHOSPHATE","company_name":"","drug_phase":"marketed","molecular_target":"P2X purinoceptor 3","drug_class":"Vitamin C [EPC]","quality_score":17,"revenue":null,"mechanism":""},{"drug_id":"lidocain","indication_name":"Ventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Lidocain","company_name":"Bayer","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"xylocain","indication_name":"Ventricular arrhythmia","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"xylocain","company_name":"Saint-Joseph University","drug_phase":"marketed","molecular_target":"5-hydroxytryptamine receptor 3A, Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4, Sodium channel protein type 10 subunit alpha","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":25,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04024865","title":"Domperidone and Risk of Serious Cardiac Events in Postpartum Women","phase":"","overall_status":"COMPLETED","enrollment_count":184929,"lead_sponsor_name":"Canadian Network for Observational Drug Effect Studies, CNODES","has_results":false},{"nct_id":"NCT06607471","title":"Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study.","phase":"","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"Scientific Institute San Raffaele","has_results":false},{"nct_id":"NCT06763549","title":"COR-INSIGHT: Optimizing Cardiovascular and Cardiopulmonary Outcomes with AI-Driven Multiplexed Indications Using COR ECG Wearable","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":15000,"lead_sponsor_name":"Peerbridge Health, Inc","has_results":false},{"nct_id":"NCT07096973","title":"Cardiac REhabilitation COhort at the Medicine Campus DaVos to invEstigate Recovery","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Hochgebirgsklinik Davos","has_results":false},{"nct_id":"NCT06324682","title":"ConTempoRary Cardiac Stimulation in Clinical practicE: lEft, BivEntriculAr, Right, and conDuction System Pacing","phase":"","overall_status":"RECRUITING","enrollment_count":8400,"lead_sponsor_name":"University Hospital of Ferrara","has_results":false},{"nct_id":"NCT07354347","title":"Optimal Settings for Anti Tachycardia Pacing (ATP) on ICD","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":3980,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT06964464","title":"Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"University of Rochester","has_results":false},{"nct_id":"NCT07501481","title":"Arrhythmic Risk in Myocarditis Outcome Research","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1500,"lead_sponsor_name":"AZ Sint-Jan AV","has_results":false},{"nct_id":"NCT07291544","title":"Management of Supraventricular Tachycardias in Children","phase":"","overall_status":"COMPLETED","enrollment_count":1400,"lead_sponsor_name":"Paris Cardiovascular Research Center (Inserm U970)","has_results":false},{"nct_id":"NCT06061120","title":"Non-invasive Differentiation of Supraventricular Tachyarrhythmia","phase":"","overall_status":"RECRUITING","enrollment_count":1250,"lead_sponsor_name":"RWTH Aachen University","has_results":false},{"nct_id":"NCT03833089","title":"Targeted Potassium Levels for Prevention of ICD Therapy","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT04521790","title":"Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Scientific Institute San Raffaele","has_results":false},{"nct_id":"NCT04599439","title":"CMR Based Prediction of Ventricular Tachycardia Events in Healed Myocardial Infarction (DEVELOP-VT)","phase":"","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Centro Medico Teknon","has_results":false},{"nct_id":"NCT06048731","title":"Enlighten Study: The EV-ICD Post Approval Registry","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Medtronic","has_results":false},{"nct_id":"NCT06835491","title":"Prophylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac Arrest With Initial Shockable Rhythm","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":674,"lead_sponsor_name":"Versailles Hospital","has_results":false},{"nct_id":"NCT02881255","title":"Avoid Transvenous Leads in Appropriate Subjects","phase":"NA","overall_status":"COMPLETED","enrollment_count":544,"lead_sponsor_name":"Population Health Research Institute","has_results":false},{"nct_id":"NCT07517523","title":"Ventricular Arrhythmias in Acute Myocardial Infarction","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Poitiers University Hospital","has_results":false},{"nct_id":"NCT03963271","title":"Noninvasive Electrocardiographic Imaging for Individuals at Risk for Apparently Idiopathic Ventricular Fibrillation.","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Maastricht University Medical Center","has_results":false},{"nct_id":"NCT06730464","title":"Image-Based Prediction of Ventricular Tachycardia Events in Non-ischemic Cardiomyopathy","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"Centro Medico Teknon","has_results":false},{"nct_id":"NCT07077928","title":"Effects of Upgrading From Right Ventricular Pacing to Cardiac Resynchronization Therapy and Comparison With Dual-Chamber Defibrillator","phase":"","overall_status":"COMPLETED","enrollment_count":307,"lead_sponsor_name":"Bursa Postgraduate Hospital","has_results":false},{"nct_id":"NCT06949748","title":"Flecainide in Idiopathic Premature Ventricular Contractions and Related Cardiomyopathy","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"University of Athens","has_results":false},{"nct_id":"NCT04798768","title":"Effectiveness of the EMPOWER™ Modular Pacing System and EMBLEM™ Subcutaneous ICD to Communicate Antitachycardia Pacing","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":297,"lead_sponsor_name":"Boston Scientific Corporation","has_results":true},{"nct_id":"NCT04548804","title":"Better Mechanistic Understanding of and Risk Stratification for Ventricular Tachyarrhythmias Through ECGI","phase":"NA","overall_status":"UNKNOWN","enrollment_count":270,"lead_sponsor_name":"Maastricht University Medical Center","has_results":false},{"nct_id":"NCT04687111","title":"Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"Mark Ledwidge","has_results":false},{"nct_id":"NCT04056715","title":"Extended ECG Monitoring in HCM Patients","phase":"","overall_status":"COMPLETED","enrollment_count":250,"lead_sponsor_name":"iRhythm Technologies, Inc.","has_results":false},{"nct_id":"NCT07103733","title":"PRIMARY Ancillary Substudy","phase":"NA","overall_status":"RECRUITING","enrollment_count":250,"lead_sponsor_name":"Annetine Gelijns","has_results":false},{"nct_id":"NCT07020702","title":"ElectroPhySiological Characterization Of the Arrhythmia Substrate for Sudden Cardiac Death PrEdiction","phase":"NA","overall_status":"RECRUITING","enrollment_count":210,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT03029169","title":"Propafenone Versus Amiodarone in Septic Shock","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":210,"lead_sponsor_name":"Charles University, Czech Republic","has_results":false},{"nct_id":"NCT06281977","title":"Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":192,"lead_sponsor_name":"Ottawa Heart Institute Research Corporation","has_results":false},{"nct_id":"NCT03294278","title":"Epicardial Ablation in Brugada Syndrome to Prevent Sudden Death","phase":"NA","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"IRCCS Policlinico S. Donato","has_results":false},{"nct_id":"NCT06730607","title":"Image-Based Prediction of Ventricular Tachycardias in Post-Myocarditis Patients: an International Multicenter Case-control Study","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Centro Medico Teknon","has_results":false},{"nct_id":"NCT07121855","title":"Symptoms and Coping Strategies Among Patients With Implantable Cardioverter Defibrillator","phase":"","overall_status":"COMPLETED","enrollment_count":142,"lead_sponsor_name":"TC Erciyes University","has_results":false},{"nct_id":"NCT02275104","title":"Multimodal Image Processing Software to Guide Cardiac Ablation Therapy","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT06602635","title":"Hybrid Score to Predict OTVA-SOO in Patients with Wide Basal QRS","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Centro Medico Teknon","has_results":false},{"nct_id":"NCT06360003","title":"\"Right Ventricular Outflow Tract Posterior Septum Pacing\" in Predicting Ventricular Outflow Tract Ventricular Tachycardia Origin","phase":"NA","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Second Affiliated Hospital of Wenzhou Medical University","has_results":false},{"nct_id":"NCT03665324","title":"Atrial Function and Supraventricular Arrhythmia of the Veteran Athlete.","phase":"","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Rennes University Hospital","has_results":false},{"nct_id":"NCT04495712","title":"Antiarrhythmic Effects of Spironolactone in Patients With ICDs","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT07026695","title":"Transcutaneous Vagus Nerve Stimulation for Ventricular Arrhythmias","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":72,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT07201506","title":"Real-Time Intracardiac Echocardiography for Ventricular Arrhythmia Ablation","phase":"NA","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"Insel Gruppe AG, University Hospital Bern","has_results":false},{"nct_id":"NCT04905199","title":"Temporary Transvenous Pacemaker Placement by Intracavitary Electrocardiogram Monitoring","phase":"","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Hunan Provincial People's Hospital","has_results":false},{"nct_id":"NCT06360939","title":"Radiotherapy vs Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Western Sydney Local Health District","has_results":false},{"nct_id":"NCT06203262","title":"Ventricular Catheter Ablation Study (VCAS)","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Field Medical","has_results":false},{"nct_id":"NCT07137455","title":"EDEN Intracardiac Electrogram Recording and Classifying System","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":50,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT05643235","title":"Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase Inhibitors","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Northwell Health","has_results":false},{"nct_id":"NCT06864429","title":"Impact of Catheter Ablation of Frequent Premature Ventricular Complexes in Treating Subtle Left Cardiomyopathy","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT07014579","title":"Using Heart Electrical Signals to Study How Well Treatments Prevent Dangerous Heart Rhythms in Active People","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"University of Leicester","has_results":false},{"nct_id":"NCT06940752","title":"VINTAGE (Ventricular Intramyocardial Navigation for Tachycardia Ablation Guided by Electrograms) Using Commercial Off-The-Shelf (COTS) Catheters","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30,"lead_sponsor_name":"National Heart, Lung, and Blood Institute (NHLBI)","has_results":false},{"nct_id":"NCT05448716","title":"Left Atrial Strain and Supraventricular Arrhythmia Burden in Cardiac Light Chain Amyloidosis Following Chemotherapy","phase":"","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Istanbul University - Cerrahpasa","has_results":false},{"nct_id":"NCT02154750","title":"AV Delay Optimization vs. Intrinsic Conduction in Pacemaker Patients With Long PR Intervals","phase":"NA","overall_status":"COMPLETED","enrollment_count":23,"lead_sponsor_name":"University of California, San Diego","has_results":true},{"nct_id":"NCT06591260","title":"Role of Endomyocardial Biopsy and Aetiology-based Treatment in Pediatric Patients with Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management (MYOPED)","phase":"","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Scientific Institute San Raffaele","has_results":false}],"total":50},"guidelines":[{"drug_id":"norpace-cr","guideline_body":"FDA label","recommendation":"Disopyramide phosphate is indicated for the treatment of documented ventricular arrhythmias such as sustained ventricular tachycardia, that, in the judgment of the physician, are life-threatening.","line_of_therapy":"1L","evidence_grade":"B","guideline_year":null}],"source":"Drug Landscape verified database"}